Pancreatic
CA240-0030
A Randomized, Phase 2/3 Study Comparing BMS-986504 Combined with Gemcitabine and Nabpaclitaxel versus Gemcitabine and Nab-paclitaxel in Participants with Untreated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) Harboring Homozygous MTAP Deletion
Trial overview
Clinical Area
Medical Oncology
Disease
Pancreatic cancer
Disease site
Gastrointestinal (GI)
Study Phase
II
Trial Identifiers
Registration number: NCT07076121
GenesisCare Location(s)
Principal Investigator(s)